Medication info

Atorbin Tablet 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationApproval withdrawn
Ingredient · strength
Atorvastatin Calcium Trihydrate›Strength being verified
Manufacturer / importer
Novartis Korea Ltd.
Appearance
A bright yellow, double-sided, convex, round film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Approval withdrawn

MFDS item code 201505880 · Approved 2015.08.21

This product's status changed to Approval withdrawn on 2023.06.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia and prevention of cardiovascular disease (e.g., myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg only for patients who require an LDL cholesterol reduction of 45 % or greater). This medication is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to reduce LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medication is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in older patients aged 70 years or older are generally similar to those in the general adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medication higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Importer
Novartis Korea Ltd.

Efficacy & effects

Improvement of hyperlipidemia and prevention of cardiovascular disease (e.g., myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it may lower the risks associated with myocardial infarction, stroke, vascular interventions, and angina. These effects are expected to be more significant in patients with type 2 diabetes or in high-risk adults. It also contributes to reducing the risk of hospitalization due to congestive heart failure. It is effective in managing hyperlipidemia and is used to lower total cholesterol and LDL cholesterol levels while increasing HDL cholesterol. It is also used as an adjunct in patients with familial hypercholesterolemia who do not respond sufficiently to dietary therapy. Therefore, it is used for the treatment of cardiovascular diseases and dyslipidemia.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg only for patients who require an LDL cholesterol reduction of 45 % or greater). This medication is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to reduce LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medication is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in older patients aged 70 years or older are generally similar to those in the general adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medication higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle problems, so if symptoms such as muscle pain or weakness occur, discontinue use immediately and consult a physician. Individuals with liver dysfunction or active liver disease should not take this medication and should undergo regular liver function tests. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication, and fertile women should use appropriate contraceptive methods during treatment. Children under 10 years old or patients with certain genetic diseases should not take this medication. Patients with a history of alcoholism or liver disease should take this medication with caution, and elderly patients are at higher risk for myopathy, so extra care is necessary. Drug interactions may occur when taking this medication with other drugs, so it is advisable to consult a physician when used in combination with specific antibiotics, antifungals, HIV medications, certain antihypertensive drugs, and oral contraceptives. This medication may increase blood sugar levels in some patients, so those at risk of diabetes should strictly manage their blood sugar. If symptoms such as muscle pain, fatigue, or fever occur, inform a physician immediately, and if necessary, blood tests should be done to check for muscle damage. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme levels should be checked regularly. This medication should be kept out of the reach of children and stored in its original container to prevent misuse.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 150 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pain in the pharynx and larynx
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vasogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • positive leukocytes in urine
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test values
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial dizziness
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • photosensitivity reaction
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional lability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • tension
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • urinary difficulty
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypothermia
  • increased non-protein nitrogen
  • hyperlipidemia
  • facial flushing
  • gingival hypertrophy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it should be kept at room temperature between 1°C and 30°C, away from excessive heat or cold.

Appearance and packaging

Appearance

A bright yellow, double-sided, convex, round film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.